Data Sources

Every conclusion traces back to a public data source — nothing is a black box.

Source overview

TypeSourceUsed for
Drug listIndian Medicine Dataset (public GitHub dataset, junioralive/Indian-Medicine-Dataset)Medicines sold in India with composition, manufacturer, price and a discontinued flag
Prediction modelTxGNNDrug–disease association prediction
Clinical trialsClinicalTrials.govEvidence grading (NCT)
LiteraturePubMedEvidence grading (PMID)
Drug informationDrugBankIngredient mapping and target data
InteractionsDDInterDrug–drug interaction data

India has no national product-licence database that this site can download, so the drug list comes from the compiled price dataset above. CDSCO approval status is not included in it.


Licensing

Each source has its own licence — please check before citing:

  • TxGNN: academic use; cite Huang et al. (2024)
  • ClinicalTrials.gov / PubMed: US NIH public data
  • DrugBank: non-commercial use subject to its licence terms
  • Indian Medicine Dataset: public dataset on GitHub; follow the licence stated in its repository

Update frequency

Data Frequency
Discontinued status Refreshed automatically every week (Mondays) from the dataset’s CSV
Trial / literature evidence Re-collected periodically
Interaction data Reviewed quarterly

Academic citation

Huang, K., et al. (2024). A foundation model for clinician-centered drug repurposing. Nature Medicine. DOI: 10.1038/s41591-024-03233-x


About the Developer

This platform is developed and operated by 藥提醒科技有限公司 (yao.care). See About for company details, the TxGNN model background, and the full list of sites in this product line.


Disclaimer
This report is for academic research reference only and does not constitute medical advice. Always follow your physician's instructions; never adjust medication on your own. Any drug repurposing decision requires full clinical validation and regulatory review.

Reviewed by: 藥提醒科技有限公司 (yao.care)

This site uses Just the Docs, a documentation theme for Jekyll.